Folic Acid Supplementation Recommendations

Healthy Adults (Non‑Pregnant)

Routine supplementation is not required; a dietary intake of approximately 330 µg dietary folate equivalents (DFE) per day is sufficient to maintain hematologic health. 1
The Dietary Reference Intake for folate is 2.4 µg DFE per day for maintenance of normal blood parameters. 1

All women aged 12–45 years should consume 400–800 µg of folic acid daily, regardless of pregnancy intention, because about half of pregnancies are unplanned. (U.S. Preventive Services Task Force) Grade B recommendation for all women capable of pregnancy. 2
A minimum daily dose of 400 µg folic acid is advised. (USPSTF) Grade B. 2
Supplementation is best delivered as part of a multivitamin formulation. (USPSTF) Grade B. 2
The recommendation specifically includes sexually active adolescent women who are not using effective contraception. (USPSTF) Grade B. 2

Start 400–800 µg folic acid daily at least 1 month (preferably 2–3 months) before conception and continue through the first trimester (up to 12 weeks gestation). (USPSTF) Grade A for women planning pregnancy. 2
Neural‑tube closure occurs 21–28 days after conception, often before pregnancy is recognized, making pre‑conception supplementation essential. (USPSTF). 2
After the first trimester, maintain 600 µg DFE daily for the remainder of pregnancy and during lactation. (ESPEN guideline). High‑quality evidence. 1

Take 4 000–5 000 µg (4–5 mg) folic acid daily, beginning at least 12 weeks (≈3 months) before conception and continuing until 12 weeks gestation. (USPSTF) Grade A for high‑risk groups. 2
High‑risk categories include: personal or partner history of neural‑tube defect, first‑/second‑/third‑degree relative with NTD, type 1 diabetes mellitus, use of antiepileptic drugs (especially valproic acid or carbamazepine), and obesity (BMI ≥ 30 kg/m²). (USPSTF). 2
After 12 weeks gestation, reduce the dose to 400–1 000 µg daily for the remainder of pregnancy. (USPSTF). 2

Administer 4–5 mg folic acid daily, starting at least 3 months before conception. (USPSTF) Grade A for this subgroup. 2
Valproic acid and carbamazepine interfere with folate metabolism, markedly increasing the risk of neural‑tube defects. (USPSTF). 2

Treat with 1–5 mg folic acid orally each day for up to four months, or until laboratory correction of the deficiency is documented. (ESPEN guideline). High‑quality evidence. 1
After clinical resolution, switch to maintenance dosing of 330 µg DFE daily for non‑pregnant adults and 600 µg DFE daily for pregnant or lactating women. (ESPEN). High‑quality evidence. 1
Monitor folate status at baseline and repeat within three months of initiating therapy; use plasma/serum (short‑term) or red‑blood‑cell (long‑term) assays validated against microbiological methods. (ESPEN). High‑quality evidence. 1

For non‑diabetic dialysis patients, prescribe 5 mg folic acid daily; for diabetic dialysis patients, prescribe 15 mg daily. (ESPEN guideline). High‑quality evidence. 1

If oral intake is ineffective or not tolerated, give 0.1 mg folic acid per day subcutaneously, intravenously, or intramuscularly. (ESPEN guideline). High‑quality evidence. 1

Do not exceed 0.4 mg (400 µg) daily in individuals without confirmed vitamin B12 sufficiency, except during pregnancy or lactation, to avoid masking pernicious anemia. (ESPEN). High‑quality evidence. 1
Doses above 1 mg do not provide additional hematologic benefit; excess is excreted unchanged in urine. (ESPEN). High‑quality evidence. 1